A Facilitated Approach to Evaluate the Inhibitor Mode and Potency of Compounds Targeting Microsomal Prostaglandin E Synthase-1

被引:7
|
作者
Spahiu, Linda [3 ]
Stenberg, Patric [2 ,3 ]
Larsson, Charlotte [3 ]
Wannberg, Johan [3 ]
Alterman, Mathias [3 ]
Kull, Bjorn [3 ]
Nekhotiaeva, Natalia [3 ]
Morgenstern, Ralf [1 ,2 ,3 ]
机构
[1] Karolinska Inst, Inst Environm Med, SE-17177 Stockholm, Sweden
[2] NovaSAID AB, Solna, Sweden
[3] Actar AB, Solna, Sweden
基金
瑞典研究理事会;
关键词
E-2; SYNTHASE; STRUCTURAL BASIS; FUNCTIONAL-CHARACTERIZATION; COLORECTAL-CANCER; CRYSTAL-STRUCTURE; PROGRESS CURVES; BIOSYNTHESIS; CYCLOOXYGENASE-2; IDENTIFICATION; PURIFICATION;
D O I
10.1089/adt.2010.0350
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Microsomal prostaglandin E-2 synthase-1 (MPGES1) catalyzes the formation of prostaglandin E-2 from the endoperoxide prostaglandin H-2. MPGES1 expression is induced in inflammatory diseases, and this enzyme is regarded as a potential drug target. To aid in the drug discovery effort, a simple method for determination of inhibition mechanism and potency toward both prostaglandin H-2 and glutathione (GSH) has been developed. Using an assay with thiobarbituric acid-based detection, the inhibitory effects of six MPGES1 inhibitors were evaluated. The IC50 values obtained at three substrate (S) concentrations ([S] < K-M, [S] approximate to K-M, [S] > K-M) were used to estimate inhibition modality and inhibition constant values. This facilitated strategy is a useful and general screening method to evaluate the inhibitory effects of new drug compounds.
引用
收藏
页码:487 / 495
页数:9
相关论文
共 50 条
  • [1] Microsomal prostaglandin E synthase-1 and blood pressure regulation
    Yang, T.
    KIDNEY INTERNATIONAL, 2007, 72 (03) : 274 - 278
  • [2] Homo-timeric structural model of human microsomal prostaglandin E synthase-1 and characterization of its substrate/inhibitor binding interactions
    Xing, Li
    Kurumbail, Ravi G.
    Frazier, Ronald B.
    Davies, Michael S.
    Fujiwara, Hideji
    Weinberg, Robin A.
    Gierse, James K.
    Caspers, Nicole
    Carter, Jeffrey S.
    McDonald, Joseph J.
    Moore, William M.
    Vazquez, Michael L.
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2009, 23 (01) : 13 - 24
  • [3] Identification of Key Residues Determining Species Differences in Inhibitor Binding of Microsomal Prostaglandin E Synthase-1
    Pawelzik, Sven-Christian
    Uda, Narasimha Rao
    Spahiu, Linda
    Jegerschold, Caroline
    Stenberg, Patric
    Hebert, Hans
    Morgenstern, Ralf
    Jakobsson, Per-Johan
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (38) : 29254 - 29261
  • [4] Cardiovascular Biology of Microsomal Prostaglandin E Synthase-1
    Wang, Miao
    FitzGerald, Garret A.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2010, 20 (06) : 189 - 195
  • [5] Mutation of a Critical Arginine in Microsomal Prostaglandin E Synthase-1 Shifts the Isomerase Activity to a Reductase Activity That Converts Prostaglandin H2 into Prostaglandin F2α
    Hammarberg, Tove
    Hamberg, Mats
    Wetterholm, Anders
    Hansson, Henrik
    Samuelsson, Bengt
    Haeggstrom, Jesper Z.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (01) : 301 - 305
  • [6] Microsomal prostaglandin E synthase-1 exhibits one-third-of-the-sites reactivity
    He, Shan
    Wu, Yiran
    Yu, Daqi
    Lai, Luhua
    BIOCHEMICAL JOURNAL, 2011, 440 : 13 - 21
  • [7] Purification and characterization of recombinant microsomal prostaglandin E synthase-1
    Ouellet, M
    Falgueyret, JP
    Ear, PH
    Pen, A
    Mancini, JA
    Riendeau, D
    Percival, MD
    PROTEIN EXPRESSION AND PURIFICATION, 2002, 26 (03) : 489 - 495
  • [8] Inhibition of microsomal prostaglandin E synthase-1 as targeted therapy in cancer treatment
    Larsson, Karin
    Jakobsson, Per-Johan
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2015, 120 : 161 - 165
  • [9] Discovery and characterization of [(cyclopentyl)ethyl]benzoic acid inhibitors of microsomal prostaglandin E synthase-1
    Partridge, Katherine M.
    Antonysamy, Stephen
    Bhattachar, Shobha N.
    Chandrasekhar, Srinivasan
    Fisher, Matthew J.
    Fretland, Adrian
    Gooding, Karen
    Harvey, Anita
    Hughes, Norman E.
    Kuklish, Steven L.
    Luz, John G.
    Manninen, Peter R.
    McGee, James E.
    Mudra, Daniel R.
    Navarro, Antonio
    Norman, Bryan H.
    Quimby, Steven J.
    Schiffler, Matthew A.
    Sloan, Ashley V.
    Warshawsky, Alan M.
    Weller, Jennifer M.
    York, Jeremy S.
    Yu, Xiao-Peng
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (06) : 1478 - 1483
  • [10] Biarylimidazoles as inhibitors of microsomal prostaglandin E2 synthase-1
    Wu, Tom Y. H.
    Juteau, Helene
    Ducharme, Yves
    Friesen, Richard W.
    Guiral, Sebastien
    Dufresne, Lynn
    Poirier, Hugo
    Salem, Myriam
    Riendeau, Denis
    Mancini, Joseph
    Brideau, Christine
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (23) : 6978 - 6982